Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DEBORAH MD KAHAL

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1821227315
CMS profile
757260
Location
WILMINGTON, DE

General Payments · PY2018–2024

$84,827.45

  • Reported across 111 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$14,948.20

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $14,794.55 18
ViiV Healthcare Company $83.76 3
Otsuka America Pharmaceutical, Inc. $20.94 1
Lilly USA, LLC $17.54 1
GlaxoSmithKline, LLC. $16.99 1
Theratechnologies Inc. $14.42 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,971.36 4
PY2019 $10,637.69 22
PY2020 $25,174.72 26
PY2021 $7,462.72 7
PY2022 $9,023.61 7
PY2023 $15,609.15 20
PY2024 $14,948.20 25

Payment records · PY2024 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Gilead Sciences, Inc. $93.33 03/13/2024 Food and Beverage Undisputed 01/23/2026 1133812119 CMS
Gilead Sciences, Inc. $2,450.00 03/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133607270 CMS
Gilead Sciences, Inc. $40.82 03/19/2024 Travel and Lodging Undisputed 01/23/2026 1133867842 CMS
Gilead Sciences, Inc. $122.85 04/15/2024 Food and Beverage Undisputed 01/23/2026 1133812121 CMS
Gilead Sciences, Inc. $2,450.00 04/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133607272 CMS
Gilead Sciences, Inc. $43.67 04/22/2024 Travel and Lodging Undisputed 01/23/2026 1133867844 CMS
Gilead Sciences, Inc. $35.14 04/25/2024 Food and Beverage Undisputed 01/23/2026 1133812123 CMS
Gilead Sciences, Inc. $34.71 05/30/2024 Food and Beverage Undisputed 01/23/2026 1133812125 CMS
Gilead Sciences, Inc. $3,190.00 06/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133607274 CMS
Gilead Sciences, Inc. $81.10 06/05/2024 Travel and Lodging Undisputed 01/23/2026 1133867846 CMS
Gilead Sciences, Inc. $20.33 06/26/2024 Food and Beverage Undisputed 01/23/2026 1133812127 CMS
Gilead Sciences, Inc. $2,450.00 06/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133607276 CMS
Gilead Sciences, Inc. $44.82 07/01/2024 Travel and Lodging Undisputed 01/23/2026 1133867848 CMS
Gilead Sciences, Inc. $735.00 09/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133607278 CMS
Gilead Sciences, Inc. $28.97 10/23/2024 Food and Beverage Undisputed 01/23/2026 1133812129 CMS
Gilead Sciences, Inc. $2,450.00 10/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133607280 CMS
Gilead Sciences, Inc. $33.81 10/24/2024 Travel and Lodging Undisputed 01/23/2026 1133867850 CMS
Gilead Sciences, Inc. $490.00 12/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133607282 CMS
GlaxoSmithKline, LLC. $16.99 12/31/2024 Food and Beverage Undisputed 01/23/2026 1116617651 CMS
Lilly USA, LLC $17.54 02/16/2024 Food and Beverage Undisputed 01/23/2026 1136139107 CMS
Otsuka America Pharmaceutical, Inc. $20.94 01/09/2024 Food and Beverage Undisputed 01/23/2026 1118917766 CMS
Theratechnologies Inc. $14.42 01/10/2024 Food and Beverage Undisputed 01/23/2026 1092903885 CMS
ViiV Healthcare Company $32.90 01/26/2024 Food and Beverage Undisputed 01/23/2026 1112700143 CMS
ViiV Healthcare Company $33.56 02/28/2024 Food and Beverage Undisputed 01/23/2026 1112770312 CMS
ViiV Healthcare Company $17.30 12/16/2024 Food and Beverage Undisputed 01/23/2026 1112704482 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.